Sarah E. Tomassetti

Hematology

1200 N State St
Los Angeles, CA 90089

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Abnormal Eosinophils With Large, Distinctly Basophilic Granules (Harlequin Cells) on Peripheral Blood Smear: A Clue for Diagnosing Chronic Myeloid Leukemia.

Abnormal Eosinophils With Large, Distinctly Basophilic Granules (Harlequin Cells) on Peripheral Blood Smear: A Clue for Diagnosing Chronic Myeloid Leukemia.

Journal: Journal of hematology

Published: February 18, 2026

ctDNA for MRD assessment is prognostic and predictive in newly diagnosed and relapsed/refractory lymphoma.

ctDNA for MRD assessment is prognostic and predictive in newly diagnosed and relapsed/refractory lymphoma.

Journal: Blood neoplasia

Published: January 20, 2026

Doxorubicin, bleomycin, vinblastine, and dacarbazine for Hodgkin lymphoma: Real-world experience from a Los Angeles County hospital.

Doxorubicin, bleomycin, vinblastine, and dacarbazine for Hodgkin lymphoma: Real-world experience from a Los Angeles County hospital.

Journal: SAGE open medicine

Published: May 19, 2025

Evaluating Asparaginase Toxicity in Hispanic Patients With Acute Lymphoblastic Leukemia in a Large Safety-Net Hospital.

Evaluating Asparaginase Toxicity in Hispanic Patients With Acute Lymphoblastic Leukemia in a Large Safety-Net Hospital.

Journal: World journal of oncology

Published: February 07, 2025

CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy.

CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy.

Journal: World journal of oncology

Published: January 09, 2025

Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma.

Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma.

Journal: Journal of hematology

Published: September 02, 2024

Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma.

Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma.

Journal: Frontiers in oncology

Published: March 26, 2024

Real-world treatment outcomes from a retrospective cohort of patients with acute myeloid leukemia from an urban safety net hospital.

Real-world treatment outcomes from a retrospective cohort of patients with acute myeloid leukemia from an urban safety net hospital.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: February 07, 2024

Population data evidence of interdependence of the limbs of hormonal feedback loops.

Population data evidence of interdependence of the limbs of hormonal feedback loops.

Journal: The Journal of endocrinology

Published: December 12, 2023

Unexpected coccidioidomycosis presenting as lung nodules with presumptive diagnosis of malignancy.

Unexpected coccidioidomycosis presenting as lung nodules with presumptive diagnosis of malignancy.

Journal: Clinical case reports

Published: November 02, 2023

Diffuse large B-cell lymphoma presenting as postmenopausal bleeding.

Diffuse large B-cell lymphoma presenting as postmenopausal bleeding.

Journal: Clinical case reports

Published: August 21, 2023

A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib.

A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib.

Journal: Clinical case reports

Published: June 15, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026